Drug Profile
Pivagabine - CeNeRx BioPharma
Alternative Names: CXB 722Latest Information Update: 28 Jun 2013
Price :
$50
*
At a glance
- Originator CeNeRx BioPharma
- Class Aminobutyric acids; Antidepressants
- Mechanism of Action Corticotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Anxiety disorders; Depressive disorders
Most Recent Events
- 28 Jun 2013 Discontinued - Phase-II for Anxiety disorders in USA (PO)
- 28 Jun 2013 Discontinued - Phase-II for Depressive disorders in USA (PO)
- 09 Jan 2009 CeNeRx completes a phase I trial in Healthy volunteers in the US